Is Synopsys Worth $84 Billion After Its FY2027 Guidance Shock?

NEW YORK — Synopsys delivered fiscal 2027 guidance so far above Wall Street’s models this week that it forced a round of hurried price-target revisions — and yet, at $489.90, the stock still sits nearly 10% below its 52-week high.

A Tape That’s Finally Rewarding the Picks-and-Shovels Names

The broader technology tape has been running hot on AI enthusiasm for months, but the gains have been uneven. This week, that changed — at least for the infrastructure layer. The Philadelphia Semiconductor Index gained 2.18% on the week, with Broadcom climbing 3.35% and ON Semiconductor surging 6.01%. That sector lift matters for Synopsys because it confirms what the earnings report suggested: AI demand is now translating into real design activity, not just future projections.

Tesla’s Q3 delivery beat — 486,532 vehicles against expectations near 461,000 — provided a sentiment tailwind across growth names broadly, easing some of the macro anxiety that has weighed on high-multiple technology stocks. As we covered earlier this week, markets have shown a notable ability to shrug off mixed macro data when company-specific catalysts are strong enough. Synopsys gave the Street exactly that kind of catalyst.

The macro backdrop remains complicated, though. September’s jobs report — a miss of historic proportions at just 29,000 payrolls — has scrambled Fed rate expectations for the balance of the year, as detailed in our analysis of the October rate hike outlook. For Synopsys, a rate-cut environment is structurally supportive: lower discount rates mechanically expand the present value of long-duration earnings, and SNPS is squarely in that category with a $10.9 billion backlog and multiyear customer agreements.

Data Visual

Synopsys Revenue Growth vs. Analyst Consensus — FY2024 to FY2027 Guidance

Shows how Synopsys revenue trajectory has accelerated beyond analyst consensus expectations, driven by Ansys integration and AI EDA demand.

Values in $B

The Business: EDA, AI, and the Ansys Factor

Synopsys occupies a near-duopoly position in electronic design automation alongside Cadence Design Systems. Its software is used by every major semiconductor company on earth to design chips — there is no credible substitute at scale. That structural position is important context when evaluating the AI story: Synopsys doesn’t just benefit from AI chip demand, it is a mandatory cost of producing those chips.

The $35 billion acquisition of Ansys, which closed earlier in 2026, transformed Synopsys from a pure EDA company into a broader engineering simulation platform. The Ansys contribution to FY2026 revenue is now expected at approximately $2.98 billion — a number that explains much of the reported 42.4% year-over-year revenue growth. Separating organic from acquired growth matters here: the core EDA segment grew 8.5% year-over-year, solid but not spectacular. Design IP grew roughly 11%. Neither figure alone justifies the multiple.

What does shift the calculus is the strategic logic of the combination. Ansys brings simulation and analysis tools used across aerospace, automotive, and industrial applications — markets that are themselves undergoing AI-driven redesign cycles. Multiyear agreements announced with Amazon and OpenAI this week suggest that hyperscalers are now embedding Synopsys tools directly into their custom silicon pipelines, which is a materially different customer relationship than a traditional EDA license.

The Numbers: Growth Is Real, But the Multiple Is Doing Heavy Lifting

Synopsys shares trade at a 42x EV/EBITDA multiple. That is a significant premium to the broader software sector and roughly double where the stock traded before the AI design cycle accelerated. Whether that multiple is justified depends entirely on whether the FY2027 guidance holds.

The guidance is genuinely impressive on its face. FY2027 revenue guidance of $11.1 billion to $11.2 billion compares to a prior consensus of $10.8 billion — a $350 million upside surprise. Adjusted EPS guidance of $19.04 to $19.12 dwarfs the $16.78 consensus by more than $2.25 per share. Non-GAAP operating margins are guiding to 41.5% for the full FY2026 year, and the company generated $746 million in free cash flow in Q3 alone.

Q3 2026 results, reported August 26, showed EPS of $3.91 against a $3.67 consensus — a $0.24 beat. Revenue of $2.48 billion cleared estimates of $2.44 billion. GAAP EPS came in at $2.84, including a gain from the divestiture of the processor IP solutions business. That divestiture also explains the modest quarter-over-quarter decline in backlog — the $10.9 billion figure is clean of that business. Full-year FY2026 revenue guidance has been raised to $9.69 billion to $9.74 billion.

The bear case, stated plainly: much of the EPS growth story is non-GAAP, the Ansys integration is still early, and the company is simultaneously managing a divestiture and a $1 billion buyback program. Integration costs tend to surface in GAAP figures, and the $0.93 gap between GAAP and non-GAAP EPS in Q3 deserves scrutiny. The free cash flow yield at the current market cap of roughly 3.6% annualized from Q3 alone is not unreasonable, but it assumes the integration doesn’t consume meaningfully more capital than disclosed.

Data Visual

Analyst Price Target Range vs. Current Price — SNPS October 2026

Illustrates the spread between current trading price and the range of 12-month analyst price targets, highlighting both upside potential and the outlier bear case.

Values in $

What the Analysts Are Actually Saying

The consensus is unusually lopsided. Of 26 analysts covering Synopsys, 22 rate it a buy, two hold, and just one sell — a distribution that should itself give contrarian traders pause. Extreme bullish consensus has historically preceded periods of elevated volatility when any element of the thesis disappoints.

The outlier on the other side is BNP Paribas Exane, which upgraded from underperform to neutral on September 24 but set only a $420 target — essentially flat to current prices. That neutral call with a below-market target is the closest thing to a skeptical voice in the room, and it’s worth understanding the logic: BNP’s argument implicitly questions whether the Ansys revenue contribution is as high-quality and recurring as the bull thesis assumes.

The average 12-month price target of $545.93 across all 26 analysts implies roughly 11% upside from current levels — modest by the standards of what the highest-conviction bulls are projecting, but meaningful in a market where the risk-free rate remains elevated. For context on how earnings expectations across the broader market are evolving, our coverage of this week’s key earnings catalysts provides useful framing.

The planned $1 billion share repurchase — representing roughly 1.2% of the current market cap — provides a modest technical floor, though it’s contingent on market conditions. With 191.64 million shares outstanding, the buyback would retire approximately 2 million shares at current prices, a meaningful but not transformational capital return for a company this size.

The Levels That Will Decide the Next Move

Synopsys sits in an interesting technical position. The stock is well off its 52-week low of $362.55 — up 35% from that trough — but remains stuck nearly 9% below the $539.48 peak. That gap represents unfinished business for bulls and a clear failure point for bears.

The FY2027 guidance shock should, in theory, be enough to push through $539. The fact that it hasn’t yet — at least through Thursday’s close — suggests either that the market is waiting for confirmation of Ansys integration progress, or that the valuation multiple is already discounting much of the good news. Both explanations can be simultaneously true.

The upcoming Q4 FY2026 earnings report — expected in November — is the next major catalyst. That print will give the first clean read on whether the Ansys business is tracking to the $2.98 billion full-year contribution target and whether non-GAAP margin expansion is translating into free cash flow at the pace the $1 billion buyback commitment implies. As discussed in our chip sector analysis earlier this week, the semiconductor design ecosystem is performing, but the broader tape is not uniformly buying every AI-adjacent story at face value.

The Synopsys thesis is internally consistent: a duopoly EDA business now expanded into engineering simulation, with hyperscaler partnerships anchoring multiyear demand, a $10.9 billion backlog providing revenue visibility, and guidance that cleared consensus by a margin wide enough to shake complacent bears. None of that is fabricated. The honest uncertainty is whether 42x EBITDA is pricing in a flawless integration at a moment when the integration is still happening — and whether the Amazon and OpenAI agreements, however significant they sound, will show up in reported revenue on a timeline that satisfies a market running out of patience with promises.

Watch the Q4 earnings date closely. Watch the $539 resistance level on any AI sector lift next week. And watch what happens to GAAP EPS relative to non-GAAP EPS in the next two quarters — that spread, more than any headline number, will tell you whether the Ansys acquisition is creating real economic value or just accounting complexity.